Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
U.S. Payrolls Rise by 295K, Jobless Rate Falls to 5.5%
35:36 - U.S. employers added 295,000 jobs in February, topping analyst estimates as the unemployment rate dropped to 5.5 percent. Bloomberg’s Peter Cook breaks down the numbers on “In the Loop.” (Source: Bloomberg)
  • Job Market Isn’t Tight Yet But Getting There: Krueger
  • How to Invest in Energy and Where the Jobs Are
  • Amazon Targets Chinese Shoppers on Alibaba’s Tmall